215 related articles for article (PubMed ID: 30577431)
1. The Identification and Interpretation of
Patel MB; Wang J
High Throughput; 2018 Dec; 8(1):. PubMed ID: 30577431
[TBL] [Abstract][Full Text] [Related]
2. Identification of recurrent noncoding mutations in B-cell lymphoma using capture Hi-C.
Cornish AJ; Hoang PH; Dobbins SE; Law PJ; Chubb D; Orlando G; Houlston RS
Blood Adv; 2019 Jan; 3(1):21-32. PubMed ID: 30606723
[TBL] [Abstract][Full Text] [Related]
3. Comparison of different functional prediction scores using a gene-based permutation model for identifying cancer driver genes.
Nono AD; Chen K; Liu X
BMC Med Genomics; 2019 Jan; 12(Suppl 1):22. PubMed ID: 30704472
[TBL] [Abstract][Full Text] [Related]
4. Cis-regulatory somatic mutations and gene-expression alteration in B-cell lymphomas.
Mathelier A; Lefebvre C; Zhang AW; Arenillas DJ; Ding J; Wasserman WW; Shah SP
Genome Biol; 2015 Apr; 16(1):84. PubMed ID: 25903198
[TBL] [Abstract][Full Text] [Related]
5. Altered TERT promoter and other genomic regulatory elements: occurrence and impact.
Heidenreich B; Kumar R
Int J Cancer; 2017 Sep; 141(5):867-876. PubMed ID: 28407294
[TBL] [Abstract][Full Text] [Related]
6. The search for cis-regulatory driver mutations in cancer genomes.
Poulos RC; Sloane MA; Hesson LB; Wong JW
Oncotarget; 2015 Oct; 6(32):32509-25. PubMed ID: 26356674
[TBL] [Abstract][Full Text] [Related]
7. Diverse noncoding mutations contribute to deregulation of cis-regulatory landscape in pediatric cancers.
He B; Gao P; Ding YY; Chen CH; Chen G; Chen C; Kim H; Tasian SK; Hunger SP; Tan K
Sci Adv; 2020 Jul; 6(30):eaba3064. PubMed ID: 32832663
[TBL] [Abstract][Full Text] [Related]
8. Identification of coding and non-coding mutational hotspots in cancer genomes.
Piraino SW; Furney SJ
BMC Genomics; 2017 Jan; 18(1):17. PubMed ID: 28056774
[TBL] [Abstract][Full Text] [Related]
9. Quantitative Trait Loci Identify Functional Noncoding Variation in Cancer.
Heyn H
PLoS Genet; 2016 Mar; 12(3):e1005826. PubMed ID: 26938653
[TBL] [Abstract][Full Text] [Related]
10. Identification of High-Impact cis-Regulatory Mutations Using Transcription Factor Specific Random Forest Models.
Svetlichnyy D; Imrichova H; Fiers M; Kalender Atak Z; Aerts S
PLoS Comput Biol; 2015 Nov; 11(11):e1004590. PubMed ID: 26562774
[TBL] [Abstract][Full Text] [Related]
11. Whole-genome mutational landscape and characterization of noncoding and structural mutations in liver cancer.
Fujimoto A; Furuta M; Totoki Y; Tsunoda T; Kato M; Shiraishi Y; Tanaka H; Taniguchi H; Kawakami Y; Ueno M; Gotoh K; Ariizumi S; Wardell CP; Hayami S; Nakamura T; Aikata H; Arihiro K; Boroevich KA; Abe T; Nakano K; Maejima K; Sasaki-Oku A; Ohsawa A; Shibuya T; Nakamura H; Hama N; Hosoda F; Arai Y; Ohashi S; Urushidate T; Nagae G; Yamamoto S; Ueda H; Tatsuno K; Ojima H; Hiraoka N; Okusaka T; Kubo M; Marubashi S; Yamada T; Hirano S; Yamamoto M; Ohdan H; Shimada K; Ishikawa O; Yamaue H; Chayama K; Miyano S; Aburatani H; Shibata T; Nakagawa H
Nat Genet; 2016 May; 48(5):500-9. PubMed ID: 27064257
[TBL] [Abstract][Full Text] [Related]
12. Candidate Cancer Driver Mutations in Distal Regulatory Elements and Long-Range Chromatin Interaction Networks.
Zhu H; Uusküla-Reimand L; Isaev K; Wadi L; Alizada A; Shuai S; Huang V; Aduluso-Nwaobasi D; Paczkowska M; Abd-Rabbo D; Ocsenas O; Liang M; Thompson JD; Li Y; Ruan L; Krassowski M; Dzneladze I; Simpson JT; Lupien M; Stein LD; Boutros PC; Wilson MD; Reimand J
Mol Cell; 2020 Mar; 77(6):1307-1321.e10. PubMed ID: 31954095
[TBL] [Abstract][Full Text] [Related]
13. [Lung cancer molecular testing, what role for Next Generation Sequencing and circulating tumor DNA].
Pécuchet N; Legras A; Laurent-Puig P; Blons H
Ann Pathol; 2016 Jan; 36(1):80-93. PubMed ID: 26803564
[TBL] [Abstract][Full Text] [Related]
14. Advances in computational approaches for prioritizing driver mutations and significantly mutated genes in cancer genomes.
Cheng F; Zhao J; Zhao Z
Brief Bioinform; 2016 Jul; 17(4):642-56. PubMed ID: 26307061
[TBL] [Abstract][Full Text] [Related]
15. Genome Sequencing and RNA-Motif Analysis Reveal Novel Damaging Noncoding Mutations in Human Tumors.
Singh B; Trincado JL; Tatlow PJ; Piccolo SR; Eyras E
Mol Cancer Res; 2018 Jul; 16(7):1112-1124. PubMed ID: 29592900
[TBL] [Abstract][Full Text] [Related]
16. Promoter capture Hi-C-based identification of recurrent noncoding mutations in colorectal cancer.
Orlando G; Law PJ; Cornish AJ; Dobbins SE; Chubb D; Broderick P; Litchfield K; Hariri F; Pastinen T; Osborne CS; Taipale J; Houlston RS
Nat Genet; 2018 Oct; 50(10):1375-1380. PubMed ID: 30224643
[TBL] [Abstract][Full Text] [Related]
17. Driver and passenger mutations in cancer.
Pon JR; Marra MA
Annu Rev Pathol; 2015; 10():25-50. PubMed ID: 25340638
[TBL] [Abstract][Full Text] [Related]
18. Identification of altered cis-regulatory elements in human disease.
Mathelier A; Shi W; Wasserman WW
Trends Genet; 2015 Feb; 31(2):67-76. PubMed ID: 25637093
[TBL] [Abstract][Full Text] [Related]
19. Identification of Single Nucleotide Non-coding Driver Mutations in Cancer.
Gan KA; Carrasco Pro S; Sewell JA; Fuxman Bass JI
Front Genet; 2018; 9():16. PubMed ID: 29456552
[TBL] [Abstract][Full Text] [Related]
20. Cancer whole-genome sequencing: present and future.
Nakagawa H; Wardell CP; Furuta M; Taniguchi H; Fujimoto A
Oncogene; 2015 Dec; 34(49):5943-50. PubMed ID: 25823020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
